StockNews.com initiated coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report issued on Friday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright raised their price target on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
Read Our Latest Analysis on SNES
SenesTech Trading Up 6.7 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Featured Articles
- Five stocks we like better than SenesTech
- What is a support level?
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- Want to Profit on the Downtrend? Downtrends, Explained.
- How AI Implementation Could Help MongoDB Roar Back in 2025
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
